產(chǎn)品分類
Products產(chǎn)品中心/ PRODUCTS
簡(jiǎn)要描述:激光多普勒適合對(duì)多種組織器官進(jìn)行點(diǎn)式或線式的快速掃描,我們可以根據(jù)您的研究對(duì)象和實(shí)驗(yàn)方向,推薦合適的型號(hào)和配置,敬請(qǐng)
聯(lián)系電話:021-54377179
品牌 | 玉研儀器 | 產(chǎn)地類別 | 國(guó)產(chǎn) |
---|---|---|---|
應(yīng)用領(lǐng)域 | 生物產(chǎn)業(yè),制藥 |
激光多普勒適合對(duì)多種組織器官進(jìn)行點(diǎn)式或線式的快速掃描,我們可以根據(jù)您的研究對(duì)象和實(shí)驗(yàn)方向,推薦合適的型號(hào)和配置,敬請(qǐng)。
LAB型號(hào)的廣泛應(yīng)用于腦缺血實(shí)驗(yàn)、皮膚肌肉血流量測(cè)定、臟器血流量測(cè)定、皮瓣血流量、牙齦牙髓測(cè)定等各種器官、組織血流量測(cè)定。
型號(hào):LAB 單通道型號(hào)
型號(hào):LAB 2ch 雙通道型號(hào)
激光的主要功能特點(diǎn):
· 用于大鼠、小鼠腦血流測(cè)定,各組織臟器血流測(cè)定等;
· 測(cè)試范圍廣,根據(jù)所要檢測(cè)的組織選用相應(yīng)的探頭;
· 探頭校準(zhǔn)數(shù)據(jù)自動(dòng)存儲(chǔ)于芯片中,實(shí)現(xiàn)了探頭的免校準(zhǔn),即插即用;
· 分析軟件功能強(qiáng)大,自動(dòng)生成報(bào)告,提供長(zhǎng)時(shí)間連續(xù)監(jiān)測(cè);
· 可選配多通道配置,同時(shí)對(duì)多多個(gè)部位或只動(dòng)物進(jìn)行測(cè)量;
· 可將多臺(tái)主機(jī)與一臺(tái)計(jì)算機(jī)相連;
主要參數(shù):
· 用于連續(xù)測(cè)量組織血流
· 測(cè)試激光:780nm 半導(dǎo)體激光,CLASS 1M 級(jí)別
· 信號(hào)帶寬:24HZ-24KHZ
· 時(shí)間常數(shù):0.1, 1, 3 sec
· 測(cè)定項(xiàng)目:組織血流量:0–1000.0(mL/min/100g 相當(dāng)),血流變化曲線
· 受光強(qiáng)度模擬信號(hào)輸出:0– 10V
· 血流模擬信號(hào)輸出:0– 10V
· 光纖探針:100/140 μm
· 測(cè)定范圍:約 1mm 直徑范圍內(nèi)
· 測(cè)定深度:0.5mm – 1mm
· 工作溫度范圍:5-40℃
· 使用濕度范圍:0-90%
激光多普勒血流有多種款式和型號(hào)可選,可提供:大、小鼠腦血流量測(cè)量(腦缺血模型)皮膚肌肉血流量測(cè)量、動(dòng)物海馬血流量測(cè)量、皮瓣灌注量測(cè)量、血管活性研究測(cè)量、牙齦血流量測(cè)量、各組織臟器血流量(肝、脾、腎等)測(cè)量、腸系膜血流量測(cè)量、燒傷創(chuàng)面血流灌注量測(cè)量;組織氧含量測(cè)量、糖尿病足的足趾末端壓力測(cè)定等。敬請(qǐng)。
參考文獻(xiàn):
1. Yamanaka H, Yamaoka T, Mahara A, et al. Tissue-engineered submillimeter-diameter vascular grafts for free flap survival in rat model. Biomaterials. 2018;179:156-163. doi:10.1016/j.biomaterials.2018.06.022.
2. Liu Y, Mahara A, Kambe Y, et al. Endothelial cell adhesion and blood response to hemocompatible peptide 1 (HCP-1), REDV, and RGD peptide sequences with free N-terminal amino groups immobilized on a biomedical expanded polytetrafluorethylene surface. Biomater Sci. 2021;9(3):1034-1043. doi:10.1039/d0bm01396j.
3. Nosaka M, Ishida Y, Kimura A, et al. Crucial Involvement of IL-6 in Thrombus Resolution in Mice via Macrophage Recruitment and the Induction of Proteolytic Enzymes. Front Immunol. 2020;10:3150.doi:10.3389/fimmu.2019.03150.
4. Fukumoto Y, Tanaka KF, Parajuli B, et al. Neuroprotective effects of microglial P2Y1 receptors against ischemic neuronal injury. J Cereb Blood Flow Metab. 2019;39(11):2144-2156. doi:10.1177/0271678X18805317.
5. Morihara R, Yamashita T, Osakada Y, et al. Efficacy and safety of spot heating and ultrasound irradiation on in vitro and in vivo thrombolysis models. J Cereb Blood Flow Metab. 2022;42(7):1322-1334. doi:10.1177/0271678X221079127.
6. Nosaka M, Ishida Y, Kimura A, et al. Contribution of the TNF-α (Tumor Necrosis Factor-α)-TNF-Rp55 (Tumor Necrosis Factor Receptor p55) Axis in the Resolution of Venous Thrombus. Arterioscler Thromb Vasc Biol. 2018;38(11):2638-2650. doi:10.1161/ATVBAHA.118.311194.
7. Tanaka M, Ogaeri T, Samsonov M, et al. The 5α-Reductase Inhibitor Finasteride Exerts Neuroprotection Against Ischemic Brain Injury in Aged Male Rats. Transl Stroke Res. 2019;10(1):67-77. doi:10.1007/s12975-018-0624-0.
8. Sakata Y, Yoshida C, Fujiki Y, et al. Effects of Casein Hydrolysate Ingestion on Thermoregulatory Responses in Healthy Adults during Exercise in Heated Conditions: A Randomized Crossover Trial. Nutrients. 2020;12(3):867. doi:10.3390/nu12030867.
:,
:
yuyanbio
:yuyanbio